医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asterand Bioscience Acquires AdeptBio LLC

2015年08月11日 PM10:00
このエントリーをはてなブックマークに追加


 

DETROIT

Asterand Bioscience, Inc. is pleased to announce the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens.

“We are delighted to have AdeptBio join our organization,” says Peter Ferrigno, CCO of Asterand Bioscience. “Together, we will strengthen our partnership with the pharmaceutical and diagnostic community; providing unparalleled quality samples, highly regulated collection and tailored specifications, for their research needs.”

Dr. Lee Schwartzberg, founder of AdeptBio, LLC, added, “The development of new targeted therapies and companion diagnostics rely on availability of tissues, and increasingly biofluids, linked to deep clinical data. Joining AdeptBio’s network with Asterand Bioscience’s network will strengthen their ability to partner and serve the pharmaceutical and diagnostic community.”

AdeptBio’s people and supply network will be incorporated into Asterand Bioscience’s existing custom procurement offering, expanding our exceptional global network of more than 80 collaborating donor institutions. This individually managed custom collection service allows Asterand Bioscience to deliver human tissues, biofluids, and accompanying clinical information in a manner which is most compatible with specific experimental needs of the pharmaceutical and diagnostic community.

About Asterand Bioscience

Asterand Bioscience is the leading global provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with increased likelihood of clinical success.

Asterand Bioscience has a well-established human tissue heritage, having been formed in 2006 through the merger of Asterand (founded 2000), a human tissue biorepository and Pharmagene (founded 1996) a human tissue-based drug discovery company. With this background and capability in human tissue procurement, characterization and research tools, Asterand Bioscience is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical, biotechnology and diagnostic companies, as well as academia. From our offices in Detroit, MI and Royston, U.K. our employees are focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150811005203/en/

CONTACT

Asterand Bioscience, Inc.
Kay Wilson
Phone (001) 313 263 0913
kay.wilson@asterandbio.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent